Veradigm Inc traded at $4.89 this Monday September 14th, increasing $0.29 or 6.30 percent since the previous trading session. Looking back, over the last four weeks, Veradigm gained 1.21 percent. Over the last 12 months, its price rose by 5.16 percent. Looking ahead, we forecast Veradigm Inc to be priced at 4.50 by the end of this quarter and at 4.22 in one year, according to Trading Economics global macro models projections and analysts expectations.
Allscripts Healthcare Solutions, Inc. is a healthcare information technology solutions and services provider. The Company operates through two segments: Core Clinical and Financial Solutions, and Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for patient engagement, integrated clinical and financial management solutions, which primarily include electronic health record-related software, financial and practice management software, related installation, support and maintenance, outsourcing, private cloud hosting and revenue cycle management. The Data, Analytics and Care Coordination segment is engaged in practice reimbursement, payer and life sciences solutions, which offers physician practices, payers, life sciences companies and other healthcare stakeholders.